Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF The Lancet Neurology, Early Online Publication, 7 March 2012. Summary Background In ROCKET AF, rivaroxaban was non-inferior to adjusted-dose warfarin in preventing stroke or systemic embolism among patients with atrial fibrillation (AF). […]
Pennlive: By Body and Mind staff – Published: Tuesday, March 06, 2012, 12:06 AM. Timing is everything in the brain. When a head injury, disease or behavioral disorder disrupts that carefully synchronized cranial clock, everything from breathing and body movements to intellect and emotion can be undermined. But a relatively new therapy known asInteractive Metronome has restored the internal timepiece […]
Cardiology News Digital Network: By: MARK S. LESNEY, March 05, 2012. Because anticoagulation is a balancing act between the prevention of clots and the risk of major bleeds, tremendous efforts have been made to find the safest, most effective drugs possible. The foundations of anticoagulant therapy – warfarin (taken orally) and heparin (taken intravenously) – are […]
News.medill.northwestern.edu: BY RIAN ERVINAND THOMAS OWEN – MARCH 01, 2012. Stroke patients can now rev up recovery as a guest at the Mad Hatter’s Tea Party with the March Hare as their therapist. Playing 3-D games in a fantasy virtual reality environment such as Alice in Wonderland is a new avenue for rehabilitation and it sure beats monotonous sessions of […]
Hrsonline: March 2012. The consensus document, an update to the 2007 version, was developed in collaboration with the European Heart Rhythm Association and the European Cardiac Arrhythmia Society. Contained in the document is an extensive list of definitions for use in clinical trials, recommendations for optimal patient care and management, as well as clinical trial design […]
Results of a Propensity-Matched Analysis Matthew R. Reynolds, MD, MSc, Candace L. Gunnarsson, EdD, Tina D. Hunter, PhD,Joseph A. Ladapo, MD, PhD, Jamie L. March, MBA, Mingdong Zhang, MD, MPH, PhD and Steven C. Hao, MD – February 28, 2012. Abstract Background Patients with atrial fibrillation (AF) face significant risks of stroke and heart failure. The objective of this study was to determine […]
Science Direct: February 13, 2012 – Annie Guérina, , Jay Linb, Mehul Jhaveric, Eric Q. Wua, Andrew P. Yua, Martin Cloutiera,Genevieve Gauthiera, Joseph S. Alpertd. Abstract Background This retrospective cohort study compared rates of treatment persistence, incidences of de novo stroke, arterial embolism, and hemorrhage/bleeding, and healthcare resource use and costs between atrial fibrillation/flutter (AF/AFL) patients receiving concomitant warfarin (W) + amiodarone (A) or warfarin + other antiarrhythmic […]
Stroke.ahajournals: February 3, 2012 – Stroke.ahaJournals: Hooman Kamel, MD; S. Claiborne Johnston, MD, PhD; J. Donald Easton, MD; Anthony S. Kim, MD, MAS Abstract Background and Purpose—The cost-effectiveness of dabigatran for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack has not been directly assessed. Methods—A Markov decision model was constructed using data from the Randomized Evaluation […]
News-Medical: Published on February 23, 2012 at 8:16 AM How information is presented to a patient makes a difference in health decisions A paper from Rhode Island Hospital and Henry Ford Hospital in Detroit examines whether different presentation formats, presenter characteristics, and patient characteristics affect decision-making for patients requiring treatment for asymptomatic carotid stenosis. Based on […]
American Heart Association: Feb, 21, 2012: Andrew E. Darby, MD; John P. DiMarco, MD, PhD: Correspondence to John P. DiMarco, MD, PhD, Box 800158, Cardiovascular Division, University of Virginia Health System, Charlottesville, VA 22908. Atrial fibrillation (AF) is the most common sustained arrhythmia encountered by clinicians. The prevalence of AF increases with age, and the elderly are […]
